K-HEALTHinAIR aims to provide a scientific-based assessment of the indoor air quality (IAQ) effects on health, based on the results of the clinical studies with 350 high-risk outpatients and an extensive monitoring of chemical and biological indoor air pollutants. For this purpose, several very representative indoor locations have been selected. To identify the determinants, a deep research study on sources, interactions and main correlations with health problems will be conducted. As a result, the project will deliver affordable measures to monitor and improve IAQ and guidelines to support real interventions.
K-HEALTHinAIR seeks to assess indoor air quality in 9 different representative scenarios at a European level based on a monitoring campaign of physical, chemical and biological parameters. The study will be carried out in 5 different pilots distributed throughout Europe: Barcelona, Rotterdam, Baden – Württemberg, Poland/Austria and Norway.
K-HEALTHinAIR main goals can be summarized as follows:
• Carry out a full characterization of indoor air quality in the selected scenarios
• Evaluate the information collected and identify the determinants of people’s health in each of the scenarios
• Research the sources of the main determinants for each scenario and propose solutions to improve the healthiness of the environments
• Improve user-level monitoring solutions, make them more friendly and develop new applications basing on the information collected
• Identify relevant stakeholders in Europe and beyond and select the most suitable means of communication, dissemination and engagement for each mapped group
• Address the sustainability of the project’ results to assure the continuity and scale up of its long-term effects.
The Europe-wide consortium includes 5 research & technology organisations (CARTIF acting also as coordinator, CSIC, CIEMAT, IDIBAPS & NOFER Institute), 2 hospitals (Clinic Hospital of Barcelona and Erasmus MC), 4 universities (Escola Nacional de Saúde Pública, Universidade Nova de Lisboa, Warsaw University of Technology, Medizinische Universität Wien & University of Agder), 2 industries (MANN+HUMMEL & Atos IT Solutions and Services), 2 SMEs (INBIOT & KVELOCE) and a digital health connector (ECHAlliance).